HPN536
HPN536 is a trispecific, T-cell-activating protein-based construct, which binds to mesothelin-expressing tumor cells, CD3ε on T cells, and to serum albumin. HPN536 specifically redirects T cells for potent redirected lysis of mesothelin-expressing cancer cells with concomitant T-cell activation[1].
Product Specifications
UNSPSC
12352203
Target
CD3
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
99.00
Molecular Weight
(52.90 kDa)
References & Citations
[1]Molloy ME, et al. Preclinical Characterization of HPN536, a Trispecific, T-Cell-Activating Protein Construct for the Treatment of Mesothelin-Expressing Solid Tumors. Clin Cancer Res. 2021 Mar 1;27 (5) :1452-1462.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL506799V 500 µL Each
Arhgap1 Mouse shRNA Lentiviral Particle (Locus ID 228359)
Sign In for Pricing
View Details 
orb3114591 100 µg
PKC theta/PRKCQ Rabbit Polyclonal Antibody (Fluoro647)
Sign In for Pricing
View Details 
SR305341 1 Kit
AF10 (mLLT10) Human siRNA Oligo Duplex (Locus ID 8028)
Sign In for Pricing
View Details 